Literature DB >> 7954177

Toxic effects of theophylline caused by fluvoxamine.

A M van den Brekel1, L Harrington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7954177      PMCID： PMC1337329     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  [Possible interaction between theophylline and fluvoxamine].

Authors:  P Diot; A P Jonville; F Gerard; M Bonnelle; E Autret; M Breteau; E Lemarie; M Lavandier
Journal:  Therapie       Date:  1991 Mar-Apr       Impact factor: 2.070

2.  Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.

Authors:  J Schwartz; L Jauregui; J Lettieri; K Bachmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 3.  Epidemiology of chronic obstructive pulmonary disease.

Authors:  D L Sherrill; M D Lebowitz; B Burrows
Journal:  Clin Chest Med       Date:  1990-09       Impact factor: 2.878

4.  The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

Authors:  H K Crewe; M S Lennard; G T Tucker; F R Woods; R E Haddock
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 5.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

6.  Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy.

Authors:  A D Sperber
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606
  6 in total
  6 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Mood disorders and chronic obstructive pulmonary disease: current research and future needs.

Authors:  Greg L Clary; Scott M Palmer; P Murali Doraiswamy
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 4.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 5.  Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Authors:  S M Cheer; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.